Remodulin 1 mg (Treprostinil (Treprostinil Sodium) SOLUTION) 1 MG

Remodulin 1 mg is a solution containing treprostinil sodium, used for managing certain circulatory conditions. This intravenous medication is designed to support vascular health and improve blood flow.

Strength

1 MG

Pack Size

20ML

Manufacturer / TM Owner

UNITED THERAPEUTICS CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Remodulin 1 mg is primarily used to treat conditions related to pulmonary arterial hypertension. Treprostinil sodium, the active ingredient, works to dilate blood vessels and improve circulation. This medication is often prescribed for long-term management of symptoms associated with reduced blood flow and oxygen levels in the lungs.

Side Effects

Common effects of Remodulin 1 mg may include headaches, diarrhea, and jaw pain. Some users also report nausea, dizziness, or flushing. These effects can vary and may not affect everyone who uses the medication.

Precautions & Warnings

Remodulin 1 mg should be handled with care and administered under medical supervision. It is important to follow the prescribed guidelines for use and storage. Patients should be aware of potential side effects and consult their healthcare provider if any concerns arise.

Avoid Interactions

Remodulin 1 mg may interact with other medications, including those that affect blood pressure or blood flow. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also influence the effectiveness of this medication.

Frequently Asked Questions

Remodulin 1 mg is used to manage symptoms of pulmonary arterial hypertension by improving blood flow and oxygen levels in the lungs.

Remodulin 1 mg is administered intravenously and should be handled under medical supervision.

Common side effects may include headaches, diarrhea, jaw pain, nausea, dizziness, and flushing.

Remodulin 1 mg may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Remodulin 1 mg should be used as directed by a healthcare provider and stored properly to maintain its effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.